Palivizumab use during respiratory syncytial virus outbreak in the neonatal intensive care unit

Alan S, Okulu E, Kiliç A, Atasay B, Arsan S. Palivizumab use during respiratory syncytial virus outbreak in the neonatal intensive care unit. J Hosp Infect. 2012 Aug;81(4):292-3. doi: 10.1016/j.jhin.2012.05.011. Epub 2012 Jun 20. PubMed PMID: 22727129.

We read with great interest the papers by Dizdar et al. and by O’Connell et al. about the use of palivizumab during a respiratory syncytial virus (RSV) outbreak in neonatal intensive care units (NICUs), suggesting that palivizumab administration might have a role in controlling RSV outbreak and recommended early administration of palivizumab to terminate transmission as quickly as possible.1,2 We recently experienced a similar outbreak in our NICU, and controlled it according to the suggestions made in this paper.

Disponível Em:<https://www.ncbi.nlm.nih.gov/>